Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey F DiBerto

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Neuron|August 19, 2021
The cranial windows of perceptionJeffrey F DiBerto, Bryan L Roth
Journal of Neurochemistry|November 19, 2021
Molecular insights into psychedelic drug actionSamuel T Slocum, Jeffrey F DiBerto, Bryan L Roth
Methods in Molecular Biology (Clifton, N.J.)|July 14, 2022
TRUPATH: An Open-Source Biosensor Platform for Interrogating the GPCR TransduceromeJeffrey F DiBerto, Reid H J Olsen, Bryan L Roth
Alcohol (Fayetteville, N.Y.)|September 15, 2016
Sex differences in the behavioral sequelae of chronic ethanol exposureNicholas J Jury, Jeffrey F DiBerto, Thomas L Kash, et al.
STAR Protocols|April 11, 2022
Agonist and antagonist TRUPATH assays for G protein-coupled receptorsJeffrey F DiBerto, Katie Smart, Reid H J Olsen, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 12, 2014
Different contributions of dopamine D1 and D2 receptor activity to alcohol potentiation of brain stimulation reward in C57BL/6J and DBA/2J miceEric W Fish, Jeffrey F DiBerto, Michael C Krouse, et al.
Neuropharmacology|September 9, 2019
Chronic intermittent ethanol exposure dysregulates a GABAergic microcircuit in the bed nucleus of the stria terminalisDipanwita Pati, Catherine A Marcinkiewcz, Jeffrey F DiBerto, et al.
Plos One|November 9, 2013
Changes in sensitivity of reward and motor behavior to dopaminergic, glutamatergic, and cholinergic drugs in a mouse model of fragile X syndromeEric W Fish, Michael C Krouse, Sierra J Stringfield, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 17, 2014
The G protein-biased κ-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivoKate L White, J Elliott Robinson, Hu Zhu, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
De Novo Design of κ-Opioid Receptor Antagonists Using a Generative Deep Learning FrameworkLeslie Salas-Estrada, Davide Provasi, Xing Qui, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Neuron|August 19, 2021
The cranial windows of perceptionJeffrey F DiBerto, Bryan L Roth
Journal of Neurochemistry|November 19, 2021
Molecular insights into psychedelic drug actionSamuel T Slocum, Jeffrey F DiBerto, Bryan L Roth
Methods in Molecular Biology (Clifton, N.J.)|July 14, 2022
TRUPATH: An Open-Source Biosensor Platform for Interrogating the GPCR TransduceromeJeffrey F DiBerto, Reid H J Olsen, Bryan L Roth
Alcohol (Fayetteville, N.Y.)|September 15, 2016
Sex differences in the behavioral sequelae of chronic ethanol exposureNicholas J Jury, Jeffrey F DiBerto, Thomas L Kash, et al.
STAR Protocols|April 11, 2022
Agonist and antagonist TRUPATH assays for G protein-coupled receptorsJeffrey F DiBerto, Katie Smart, Reid H J Olsen, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 12, 2014
Different contributions of dopamine D1 and D2 receptor activity to alcohol potentiation of brain stimulation reward in C57BL/6J and DBA/2J miceEric W Fish, Jeffrey F DiBerto, Michael C Krouse, et al.
Neuropharmacology|September 9, 2019
Chronic intermittent ethanol exposure dysregulates a GABAergic microcircuit in the bed nucleus of the stria terminalisDipanwita Pati, Catherine A Marcinkiewcz, Jeffrey F DiBerto, et al.
Plos One|November 9, 2013
Changes in sensitivity of reward and motor behavior to dopaminergic, glutamatergic, and cholinergic drugs in a mouse model of fragile X syndromeEric W Fish, Michael C Krouse, Sierra J Stringfield, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 17, 2014
The G protein-biased κ-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivoKate L White, J Elliott Robinson, Hu Zhu, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
De Novo Design of κ-Opioid Receptor Antagonists Using a Generative Deep Learning FrameworkLeslie Salas-Estrada, Davide Provasi, Xing Qui, et al.
Pageof 5